Stemline comes clean on patient death, but questions linger; Life sciences fund launches with €100M
• Stemline $STML has been forced to admit that it received a report that one of the patients in its pivotal study of SL-401 for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
